我国区域医药经济发展水平与医药制造业研发资金投入关系研究  

Relationship between regional level of pharmaceutical economic development and R&D capital investment in pharmaceutical manufacturing industry in China

作　　者：李宛亭 王素[1] 陈玉文[1] LI Wan-ting;WANG Su;CHEN Yu-wen(College of Business Administration,Shenyang Pharmaceutical University,Shenyang 110016,China)

机构地区：[1]沈阳药科大学工商管理学院,沈阳110016

出　　处：《中国新药杂志》2021年第1期6-12,共7页Chinese Journal of New Drugs

基　　金：辽宁省医药产业创新发展战略研究(2020lslktyb-095)。

摘　　要：本文通过实证分析我国东、中、西部医药经济发展水平与医药制造业研发资金投入之间的关系,为提高我国区域医药制造业创新水平和经济发展水平提供参考。选取1995—2016年的相关数据,基于协整理论,并进行格兰杰因果关系检验分析二者之间的关系。研究结果发现我国东、中、西部医药经济发展水平对医药制造业研发资金投入均为正向的影响,影响程度从大到小排序依次为西部地区、东部地区、中部地区。最后建议政府应当根据区域差异给予适当政策引导、资源合理配置以及资金支持,各个地区也应利用自身的优势促进区域医药经济发展,从而提升医药制造业创新水平。This paper gives an empirical research on the relationship between the regional level of pharmaceutical economic development and R&D investment of the pharmaceutical manufacturing industry in the eastern,central and western regions of China to provide reference for improving the innovation level of pharmaceutical manufacturing industry and the development level of regional economy.The relevant data from 1995 to 2016 were selected based on the co-integration theory,and the Granger causality test was conducted to analyze the influence between the two.The result indicates that the level of pharmaceutical economic development in eastern,central and western regions of China has a positive impact on the R&D input intensity of the pharmaceutical manufacturing industry.The degree of the impact in western region is higher than in eastern region,and the central region is the lowest.Finally,this paper suggests the government should provide policy guidance,rational allocation of resources and financial support according to regional differences,and each region should utilize its own advantages to promote regional pharmaceutical economic development,so as to improve the innovation level of pharmaceutical manufacturing industry.

关 键 词：医药制造业 区域医药经济发展水平 研发资金投入 协整理论 

分 类 号：R95[医药卫生—药学]